Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

NCT07159750 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT07159750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07159750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Observational
Overall status
Recruiting
Start date
January 2, 2024
Completion date
January 31, 2026
Enrollment
700 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine, headache, episodic migraine, migraine